loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of Drug Master Files (KDMF) for Regorafenib Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Bayer AG (1)

02 MSN Laboratories Private Limited (1)

03 Natco Pharma Limited (1)

filter

01 Aging Life Science Co., Ltd. (1)

02 Bayer Korea Co., Ltd. (1)

03 Classia Co., Ltd. (1)

filter

01 Regorafenib (2)

02 Regorafenib hydrate (1)

filter

01 Germany (1)

02 India (2)

URL Supplier Web Content
Bayer Korea Co., Ltd.
2013-05-22
Wed2420-5-ND
Bayer AG
Germany
Friedrich-Ebert-Str. 217-...
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Aging Life Science Co., Ltd.
2022-03-14
Number 434-45-ND
MSN Laboratories Private ...
India
(Unit-ll) Sy. No. 50, 53,...
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Classia Co., Ltd.
2019-05-29
Number 758-2-ND
Natco Pharma Limited
India
Chemical Division Mekagud...
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 755037-03-7 / Regorafenib API manufacturers, exporters & distributors?

Regorafenib manufacturers, exporters & distributors 1

82

PharmaCompass offers a list of Regorafenib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Regorafenib manufacturer or Regorafenib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Regorafenib manufacturer or Regorafenib supplier.

PharmaCompass also assists you with knowing the Regorafenib API Price utilized in the formulation of products. Regorafenib API Price is not always fixed or binding as the Regorafenib Price is obtained through a variety of data sources. The Regorafenib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Regorafenib

Synonyms

755037-03-7, Bay 73-4506, Stivarga, 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-n-methylpicolinamide, Regorafenibum, Regorafenib (bay 73-4506)

Cas Number

755037-03-7

Unique Ingredient Identifier (UNII)

24T2A1DOYB

About Regorafenib

Regorafenib is the anhydrous form of regorafenib, an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in tumor cell signaling.

Regorafenib Manufacturers

A Regorafenib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Regorafenib, including repackagers and relabelers. The FDA regulates Regorafenib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Regorafenib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Regorafenib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Regorafenib Suppliers

A Regorafenib supplier is an individual or a company that provides Regorafenib active pharmaceutical ingredient (API) or Regorafenib finished formulations upon request. The Regorafenib suppliers may include Regorafenib API manufacturers, exporters, distributors and traders.

click here to find a list of Regorafenib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Regorafenib KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Regorafenib Drug Master File in Korea (Regorafenib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Regorafenib. The MFDS reviews the Regorafenib KDMF as part of the drug registration process and uses the information provided in the Regorafenib KDMF to evaluate the safety and efficacy of the drug.

After submitting a Regorafenib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Regorafenib API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Regorafenib suppliers with KDMF on PharmaCompass.

Regorafenib Manufacturers | Traders | Suppliers

Regorafenib Manufacturers, Traders, Suppliers 1
41

We have 3 companies offering Regorafenib

Get in contact with the supplier of your choice:

  1. Bayer AG
  2. MSN Laboratories
  3. Natco Pharma
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY